Lack of association between a disease-susceptible single-nucleotide polymorphism, rs2230926 of TNFAIP3, and tumour necrosis factor inhibitor therapeutic failure in Japanese patients with rheumatoid arthritis

H MatsuokaDepartment of Rheumatology and Allergology, NHO Osaka Minami Medical Center, Kawachinagano, Japan;Department of Clinical Research, NHO Osaka Minami Medical Center, Kawachinagano, Japan

D KabataDepartment of Medical Statics, Osaka City University Graduate School of Medicine, Osaka, Japan

A TauraDepartment of Clinical Research, NHO Osaka Minami Medical Center, Kawachinagano, Japan

T MatsuiDepartment of Rheumatology, NHO Sagamihara National Hospital, Sagamihara, Japan

K TakahiDepartment of Orthopedics and Rheumatology, NHO Osaka Toneyama Medical Center, Toyonaka, Japan

F HiranoDepartment of Internal Medicine, NHO Asahikawa Medical Center, Asahikawa, Japan

M KatayamaDepartment of Rheumatology, NHO Nagoya Medical Center, Nagoya, Japan

A OkamotoDepartment of Rheumatology, NHO Himeji Medical Center, Himeji, Japan

Y SuenagaDepartment of Rheumatology, NHO Beppu Medical Center, Beppu, Japan

E SuematsuDepartment of Rheumatology, NHO Kyushu Medical Center, Fukuoka, Japan

S YoshizawaDepartment of Rheumatology, NHO Fukuoka National Hospital, Fukuoka, Japan

K OhmuraDepartment of Rheumatology and Clinical Immunology, Kyoto University, Kyoto, Japan

S ItoDepartment of Rheumatology, Niigata Rheumatic Center, Niigata, Japan

H TakaokaSection of Internal Medicine and Rheumatology, Kumamoto Shinto General Hospital, Kumamoto, Japan

E OguroDepartment of Rheumatology and Allergology, NHO Osaka Minami Medical Center, Kawachinagano, Japan

K KuzuyaDepartment of Rheumatology and Allergology, NHO Osaka Minami Medical Center, Kawachinagano, Japan

Y OkitaDepartment of Rheumatology and Allergology, NHO Osaka Minami Medical Center, Kawachinagano, Japan

C UdagawaDepartment of Clinical Research, NHO Osaka Minami Medical Center, Kawachinagano, Japan;Department of Molecular Chemistry, Faculty of Pharmacy, Osaka Ohtani University, Tondabayashi, Osaka, Japan

M YoshimuraDepartment of Rheumatology and Allergology, NHO Osaka Minami Medical Center, Kawachinagano, Japan

S TeshigawaraDepartment of Rheumatology and Allergology, NHO Osaka Minami Medical Center, Kawachinagano, Japan

Y HaradaDepartment of Rheumatology and Allergology, NHO Osaka Minami Medical Center, Kawachinagano, Japan

K IsodaDepartment of Rheumatology and Allergology, NHO Osaka Minami Medical Center, Kawachinagano, Japan

Y YoshidaDepartment of Rheumatology and Allergology, NHO Osaka Minami Medical Center, Kawachinagano, Japan

S OhshimaDepartment of Rheumatology and Allergology, NHO Osaka Minami Medical Center, Kawachinagano, Japan

S TohmaDepartment of Rheumatology, NHO Tokyo National Hospital, Tokyo, Japan

Y SaekiDepartment of Rheumatology and Allergology, NHO Osaka Minami Medical Center, Kawachinagano, Japan;Department of Clinical Research, NHO Osaka Minami Medical Center, Kawachinagano, JapanCorrespondence[email protected]

show all

Lack of association between a disease-susceptible single-nucleotide polymorphism, rs2230926 of TNFAIP3, and tumour necrosis factor inhibitor therapeutic failure in Japanese patients with rheumatoid arthritis

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Lack of association between a disease-susceptible single-nucleotide polymorphism, rs2230926 of TNFAIP3, and tumour necrosis factor inhibitor therapeutic failure in Japanese patients with rheumatoid arthritis

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date